No Detail Found!

Control of Refractory Hypercalcemia with Denosumab in a Case of Metastatic Parathyroid Carcinoma

Author(s)
Murat Çalapkulu Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital,Ankara,Turkey
Ozen Oz Gul Department of Endocrinology and Metabolism, Uludag University Medical School,Turkey
Soner Cander Department of Endocrinology and Metabolism, Uludag University Medical School,Turkey
Canan Ersoy Department of Endocrinology and Metabolism, Uludag University Medical School,Turkey
Erdinc Erturk Department of Endocrinology and Metabolism, Uludag University Medical School,Turkey
Muhammed Fatih Sagiroglu Department of Internal Medicine, Uludag University Medical School,Turkey
Ozlem Saraydaroglu Department of Pathology, Uludag University Medical School,Turkey
Abstract
Parathyroid carcinoma is a rare cause of hyperparathyroidism and leads to severe hypercalcemia. The etiology is not fully known. Parathyroid cancer should be considered in the di erential diagnosis, if serum calcium and parathyroid hormone levels increase, and parathyroid gland is palpable. Severe hypercalcemia is the most common cause of death in patients diagnosed with parathyroid carcinoma. Fluid replacement, diuretic therapy, bisphosphonates, and calcimimetic agents are the main treatment steps in the control of life-threatening hypercalcemia. Surgery is the primary treatment option, while denosumab is a treatment option for refractory hypercalcemia caused by parathyroid carcinoma, or for patients who are not eligible for surgery. There are few case reports in literature about denosumab treatment for parathyroid carcinoma. Herein, we report a case of a patient who presented with the complaint of leg pain and was diagnosed with parathyroid carcinoma. The elevated calcium level of the patient was controlled with denosumab.
Publication Details
Page(s) 757-759
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 30, Issue: 7, Year: 2020

Request the full text from PASTIC

Keywords
Hyperparathyroidism, Hypercalcemia, Parathyroid carcinoma, Denosumab
0

Citations

0

Downloads

56

Views